利润表
AKEBIA THERAPEUTICS, INC.
AKBA
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
236.20 | 160.18 | 194.62 | 292.60 | 213.58 | 295.31 | 335.00 | 207.74 | - | - | - | - |
|
营业成本
|
39.46 | 63.18 | 74.15 | 84.80 | 153.39 | 295.91 | 254.27 | 14.02 | - | - | - | - |
|
毛利润
|
196.73 | 97.00 | 120.47 | 207.81 | 60.18 | -0.60 | 80.73 | 193.72 | - | - | - | - |
|
营业费用
|
173.24 | 147.48 | 166.73 | 286.92 | 325.50 | 375.84 | 475.95 | 378.14 | 257.90 | 138.00 | 61.51 | 37.94 |
|
研发费用
|
62.36 | 37.65 | 63.08 | 129.11 | 147.85 | 218.49 | 322.97 | 291.01 | 230.89 | 115.79 | 43.02 | 25.40 |
|
销售、一般及行政费用
|
107.48 | 106.55 | 100.23 | 138.70 | 174.16 | 153.95 | 149.46 | 87.06 | 27.01 | 22.21 | 18.50 | 12.54 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
23.50 | -50.47 | -46.26 | -79.12 | -265.32 | -376.44 | -395.22 | -184.41 | -257.90 | -138.00 | -61.51 | -37.94 |
|
营业外收入
|
27.22 | 18.94 | 5.67 | 13.45 | 17.52 | 7.02 | -108.93 | -12.49 | - | - | - | - |
|
利息收入
|
- | - | - | - | - | - | - | - | - | 0.90 | - | - |
|
利息支出
|
8.40 | 7.10 | 6.00 | 9.50 | 10.90 | 8.90 | 0.90 | - | - | - | - | - |
|
其他营业外收入/支出
|
0.06 | 0.09 | 0.89 | 3.15 | 2.41 | 1.86 | -0.79 | 0.08 | 0.20 | -0.19 | - | - |
|
税前利润
|
-3.72 | -69.41 | -51.93 | -92.56 | -282.84 | -383.46 | -286.29 | -171.93 | - | - | - | - |
|
所得税费用
|
1.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -6.63 | -28.34 | - | - | - | - |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
-5.35 | -69.41 | -51.93 | -92.56 | -282.84 | -383.46 | -279.66 | -143.59 | -76.91 | -135.75 | -60.72 | -37.03 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
23.50 | -50.47 | -46.26 | -77.46 | -263.39 | -374.37 | -392.98 | -183.51 | -257.28 | -137.70 | -61.51 | -37.94 |
|
基本每股收益
|
-0.02 | -0.33 | -0.28 | -0.51 | -1.70 | - | - | - | - | - | - | - |
|
稀释每股收益
|
-0.02 | -0.33 | -0.28 | -0.51 | -1.70 | - | - | - | - | - | - | - |
|
加权平均股数
|
257.16 | 210.95 | 187.47 | 182.78 | 165.95 | - | - | - | - | - | - | - |
|
稀释加权平均股数
|
257.16 | 210.95 | 187.47 | 182.78 | 165.95 | - | - | - | - | - | - | - |
|
综合收益
|
-5.35 | -69.41 | -51.93 | -92.56 | -282.85 | -383.44 | -279.40 | -143.41 | -77.31 | -135.79 | -60.95 | -37.09 |